Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
Condition: Osteoarthritis, Knee Interventions: Biological: Leukocyte-Poor Platelet Rich Plasma (LP-PRP); Biological: Bone Marrow Concentrate (BMC); Other: Control group (Placebo) Sponsors: Steadman Philippon Research Institute; United States Department of Defense; Office of Naval Research (ONR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials